KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China.Lancet疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40057343无 PMCID2025-Mar-080.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Non-inferiority and vaccine titer-confirmation studies of MMR vaccine (JVC-001; measles AIK-C, mumps RIT4385, and rubella Takahashi strains) in healthy 1-year-old Japanese children.VaccinePMID 39920023无 PMCID2025-Mar-070.98未发现恶性肿瘤人群证据。待处理
Tirzepatide for Obesity Treatment and Diabetes Prevention.N Engl J MedPMID 39536238无 PMCID2025-Mar-060.98未发现恶性肿瘤人群证据。待处理
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis.N Engl J MedPMID 40043236无 PMCID2025-Mar-060.98未发现恶性肿瘤人群证据。待处理
Remibrutinib in Chronic Spontaneous Urticaria.N Engl J MedPMID 40043237无 PMCID2025-Mar-060.98未发现恶性肿瘤人群证据。待处理
Randomized controlled phase III study comparing chemotherapy alone versus conversion surgery after a remarkable response to chemotherapy in patients with initially unresectable cStage IVB or pStage IV gastric cancer (JCOG2301, Conversion study).Jpn J Clin Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39690810无 PMCID2025-Mar-050.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X).BMJ OpenPMID 40044198PMC118836182025-Mar-050.98未发现恶性肿瘤人群证据。待处理
Evaluating the effectiveness of systemic heparin during arteriovenous fistula creation by emulating a target trial.Am J EpidemiolPMID 38825327PMC121661802025-Mar-040.98未发现恶性肿瘤人群证据。待处理
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial.CirculationPMID 39556242PMC118754082025-Mar-040.98未发现恶性肿瘤人群证据。待处理
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical Trial.JAMA疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39847361PMC118809482025-Mar-040.93干预为非药物单独策略,未满足药物干预要求。无 KM 图
Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical Trial.JAMA Netw OpenPMID 40085084PMC119096092025-Mar-030.98未发现恶性肿瘤人群证据。待处理
Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial.HepatologyPMID 38875119PMC118254812025-Mar-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial.Int J Radiat Oncol Biol PhysPMID 39353477无 PMCID2025-Mar-010.90The record reports a Phase III randomized oncology trial with drug intervention, but the abstract exclusively presents acute and late toxicity results. The primary/key efficacy endpoint for this study (expected to be a time-to-event outcome like OS or DFS) is explicitly stated as not yet available ('awaited'). Therefore, it does not meet the criterion of reporting a primary or key secondary time-to-event efficacy endpoint.待处理
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.Int J Radiat Oncol Biol PhysPMID 39357788无 PMCID2025-Mar-010.95The trial is a randomized, phase III oncology study in humans with original results. However, it compares two radiation techniques (proton vs. IMRT) and does not involve a drug-containing intervention. Furthermore, the primary endpoint is a change in a patient-reported quality-of-life score (bowel health), not a time-to-event efficacy endpoint (OS, PFS, etc.) or a survival analysis with Kaplan-Meier/HR. Therefore, it does not meet the inclusion criteria.待处理
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial.Int J CancerPMID 39501485无 PMCID2025-Mar-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials.Am J PsychiatryPMID 39659157无 PMCID2025-Mar-010.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of RelabotulinumtoxinA Liquid Botulinum Toxin in the Treatment of Lateral Canthal Lines: Results From the Phase 3 READY-2 Study.Dermatol SurgPMID 39692332PMC118640472025-Mar-010.98未发现恶性肿瘤人群证据。待处理
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial.JAMA PsychiatryPMID 39693081PMC118835132025-Mar-010.98未发现恶性肿瘤人群证据。待处理
Effect of virtual reality intervention on hospitalized patients with acute pain after thoracoscopic surgery: a pilot randomized clinical trial.Int J SurgPMID 39878180PMC123727102025-Mar-010.98未发现恶性肿瘤人群证据。待处理
Neuromodulation for Children With Hemiparesis and Perinatal Stroke: A Randomized Clinical Trial.JAMA NeurolPMID 39899326PMC117917702025-Mar-010.98未发现恶性肿瘤人群证据。待处理
Comparison of a submucosal and subserosal approach in ICG-guided laparoscopic lymphadenectomy in gastric cancer patients: long-term outcomes of a phase 3 randomized clinical trial.Int J SurgPMID 39903562PMC123727242025-Mar-010.93干预为非药物单独策略,未满足药物干预要求。已完成
Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction Trial.J Card FailPMID 39182825无 PMCID2025-Mar0.98未发现恶性肿瘤人群证据。待处理
Effects of fremanezumab on migraine-associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double-blind, placebo-controlled trial.HeadachePMID 39221611PMC118842182025-Mar0.98未发现恶性肿瘤人群证据。待处理
Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial.Eur UrolPMID 39271420无 PMCID2025-Mar0.95The study is a Phase III randomized trial with oncology endpoints, but the primary experimental intervention compared is radiotherapy (hypofractionated vs. conventional fractionated), not a drug. Therefore, it does not meet the drug-containing intervention criterion for inclusion.待处理
A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age.Infect Dis (Lond)PMID 39378070无 PMCID2025-Mar0.98未发现恶性肿瘤人群证据。待处理
Exposure-Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISM.J Clin PharmacolPMID 39417209PMC118679242025-Mar0.98未发现恶性肿瘤人群证据。待处理
Immediate effects of propofol on mood: a randomized comparison of two doses in a cohort with depression.Psychopharmacology (Berl)PMID 39417860无 PMCID2025-Mar0.98未发现恶性肿瘤人群证据。待处理
Exposure-Response Analysis of Tofacitinib in Active Psoriatic Arthritis: Results from Two Phase 3 Studies.J Clin PharmacolPMID 39453735PMC118679172025-Mar0.98未发现恶性肿瘤人群证据。待处理
Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial.Lancet Infect DisPMID 39461355无 PMCID2025-Mar0.98未发现恶性肿瘤人群证据。待处理
The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial.Lancet Infect DisPMID 39461358PMC118719982025-Mar0.98未发现恶性肿瘤人群证据。待处理
Statin use and oncological outcomes in a propensity-matched cohort of nonmetastatic castration resistant prostate cancer patients of the ARAMIS trial.Urol OncolPMID 39477770无 PMCID2025-Mar0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infections.Clin Microbiol InfectPMID 39491784无 PMCID2025-Mar0.98未发现恶性肿瘤人群证据。待处理
The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial.AllergyPMID 39495086PMC118914172025-Mar0.98未发现恶性肿瘤人群证据。待处理
Short-course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy.AllergyPMID 39520181PMC118914312025-Mar0.98未发现恶性肿瘤人群证据。待处理
Durvalumab Versus Chemotherapy as First-line Treatment for Metastatic NSCLC With Tumor PD-L1 Expression of 25% or Higher: Results From the Randomized Phase 3 PEARL Study.J Thorac Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39521433无 PMCID2025-Mar0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
ONS-5010 (bevacizumab-vikg) Safety and Efficacy in Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration.Ophthalmic Surg Lasers Imaging RetinaPMID 39535413无 PMCID2025-Mar0.98未发现恶性肿瘤人群证据。待处理
Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial.Graefes Arch Clin Exp OphthalmolPMID 39538001PMC119531522025-Mar0.98未发现恶性肿瘤人群证据。待处理
Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial.Qual Life ResPMID 39565556无 PMCID2025-Mar0.45The record describes a Phase III randomized trial for high-risk prostate cancer, but the reported outcomes (testosterone recovery and quality of life) do not meet the criterion for survival, progression, recurrence, death, hazard, or time-to-event efficacy outcomes.待处理
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18).J Clin Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39571127无 PMCID2025-Mar0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Effect of intraperitoneal ropivacaine during and after cytoreductive surgery on time-interval to adjuvant chemotherapy in advanced ovarian cancer: a randomised, double-blind phase III trial.Br J AnaesthPMID 39572271PMC118670742025-Mar0.95Study is an oncology, human, randomized, phase III trial with original results. However, the primary endpoint is 'time to return to intended oncologic therapy (RIOT)', not a standard time-to-event efficacy endpoint like OS, PFS, DFS, EFS, RFS, or TTP. The intervention is intraperitoneal ropivacaine (a local anesthetic), not a systemic anti-cancer drug, so it does not meet the drug-intervention criterion. Therefore, it is excluded.待处理
Quality of life in advanced-stage, asymptomatic, non-bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful-waiting.Br J HaematolPMID 39604791无 PMCID2025-Mar0.85This is a randomized Phase III oncology trial with a drug intervention, but the primary endpoint is quality-of-life, not a time-to-event efficacy endpoint (OS, PFS, etc.) as required. Therefore, it is excluded.待处理
Dupilumab Efficacy and Safety in Children With Moderate to Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE.J Allergy Clin Immunol PractPMID 39613097无 PMCID2025-Mar0.98未发现恶性肿瘤人群证据。待处理
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39631622无 PMCID2025-Mar0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms.Neuropsychopharmacol RepPMID 39632341PMC116663402025-Mar0.98未发现恶性肿瘤人群证据。待处理
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.J Clin OncolPMID 39647999PMC118559942025-Mar0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial.J Clin OncolPMID 39671538PMC118698822025-Mar0.80The study is a randomized, oncology trial with a drug-like intervention, but it is explicitly a Phase II trial, and the primary endpoint is a biomarker (Ki-67) change, not a time-to-event efficacy endpoint. Therefore, it does not meet the required criteria for inclusion in the cohort.待处理
SB16 versus reference denosumab in postmenopausal women with osteoporosis: 18-month outcomes of a phase III randomized clinical trial.BonePMID 39674388无 PMCID2025-Mar0.98未发现恶性肿瘤人群证据。待处理
Reference Ranges and Determinants of Thyroid Function and TSH Receptor Antibodies During Early Pregnancy in Nepal.Clin Endocrinol (Oxf)PMID 39676726PMC117889472025-Mar0.98未发现恶性肿瘤人群证据。待处理
Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.J Diabetes Sci TechnolPMID 39717993PMC116691352025-Mar0.98未发现恶性肿瘤人群证据。待处理
Effect of telemedicine support for intraoperative anaesthesia care on postoperative outcomes: the TECTONICS randomised clinical trial.Br J AnaesthPMID 39753404PMC118670812025-Mar0.98未发现恶性肿瘤人群证据。待处理